arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1210.3154q-bio.BMq-bio.SC
收藏

基于潜在配体结合位点的HIV整合酶抑制剂的对接研究

Docking Studies on HIV Integrase Inhibitors Based On Potential Ligand Binding Sites

Subhomoi Borkotoky

摘要:

HIV整合酶是由Pol基因产物的C-末端部分产生的32 kDa蛋白,并且是新的抗HIV药物的有吸引力的靶标。整合酶是由逆转录病毒(如HIV)产生的酶,使其遗传物质整合到受感染细胞的DNA中。雷特格韦和埃替格韦是两种重要的抗整合酶药物。

英文摘要:

HIV integrase is a 32 kDa protein produced from the C-terminal portion of the Pol gene product, and is an attractive target for new anti-HIV drugs. Integrase is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell. Raltegravir and Elvitegravir are two important drugs against integrase.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑